HOB Biotech Group Corp.,Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 300.15 million compared to CNY 254.6 million a year ago. Revenue was CNY 300.15 million compared to CNY 254.6 million a year ago.

Net income was CNY 38.63 million compared to CNY 44.47 million a year ago. Basic earnings per share from continuing operations was CNY 0.61 compared to CNY 0.71 a year ago. Diluted earnings per share from continuing operations was CNY 0.6 compared to CNY 0.7 a year ago.